This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

If McCain Wins, So Could These Funds

One political reality has emerged from the primary madness this week: Sen. John McCain is within reach of the Republican Party nomination for president.

Intrade, a current-events wagering Web site, puts his chances of securing the Republican nomination at nearly 94%. After cleaning up on Super Tuesday in winner-take-all victories in nine of 21 states, McCain has a commanding lead in the delegate count. That includes wins California, New York, Illinois, New Jersey, and Missouri -- five of the six largest contests.

Former Massachusetts Gov. Mitt Romney, the closest competitor to the Arizona senator, announced Thursday he is suspending his campaign. With Romney gone and McCain having a 4-to-1 delegate advantage over the other challenger, former Arkansas Gov. Mike Huckabee, the Republican nomination race can be wrapped up by March 4, assuming a McCain sweep in the remaining primaries.

While I am not predicting the outcome of the general election, McCain's ascendancy invites the question, "What mutual funds or exchange-traded funds might do well during a John McCain presidency?" (To give equal time for all major candidates, I later will look at investments that would do well under a Hillary Clinton or Barack Obama presidency.)

On his Web site , McCain writes that "there are simply not enough American forces in Iraq." He has stated that he would be willing to keep troops in Iraq for 100 years if that is what it would take for victory.

As part of his Iraq strategy, McCain believes that "the U.S. must accelerate the training and equipping of Iraqi armed forces and police." He intends for the U.S. to "bolster its regional military posture" to push back against Syria and Iran aiding and abetting Iraqi violence.

Two top-performing funds that have been beaten down in the recent months are the A-rated (FSDAX)(FSDAX) and the A+-rated (PPA) (PPA). The former is an open-end fund, while the latter is an exchange-traded fund. Consider adding one, but not both to your portfolio.

Top holdings of both funds include Lockheed Martin (LMT - Get Report), Honeywell (HON - Get Report), Boeing (BA - Get Report), General Dynamics (GD - Get Report) and Raytheon (RTN - Get Report).

If you believe that McCain will win the presidency, then the "Straight Talk Express" is telegraphing higher levels of spending on military and defense goods. He also promises to "return astronauts to the moon in preparation for a manned mission to Mars. That could light the next booster stage under these stocks.

His support for embryonic stem-cell research is a signal that not only could federal funding be restored, but anti-science bans may be lifted on institutions putting together public-private research partnerships. Or, as McCain puts it, "dedicate federal research on the basis of sound science resulting in greater focus on care and cure of chronic disease."

The B-rated (XBI) (XBI) gained more than 29% in 2007, and also has fallen in the current rough market so far this year. The top holdings of Celgene (CELG - Get Report), Cepheid (CPHD - Get Report), Biogen Idec (BIIB - Get Report), Genentech (DNA) and Genzyme (GENZ) are positioned to benefit from new funding of research initiatives.

Even if John McCain becomes the 44th president of the United States, these funds still could fall in value. If McCain loses his temper, helping Huckabee make a huge comeback, the defense funds ought to still do well, but the science and biotechnology funds would become less attractive.

If McCain loses to either Clinton or Obama, biotechnology ought to prosper, and the defense funds should do all right because there is no choice but to rebuild and replace military equipment worn out in Iraq and Afghanistan.
Kevin Baker became the senior financial analyst for TSC Ratings upon the August 2006 acquisition of Weiss Ratings by TheStreet.com, covering mutual funds. He joined the Weiss Group in 1997 as a banking and brokerage analyst. In 1999, he created the Weiss Group's first ratings to gauge the level of risk in U.S. equities. Baker received a B.S. degree in management from Rensselaer Polytechnic Institute and an M.B.A. with a finance specialization from Nova Southeastern University.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
XBI $250.26 1.30%
PPA $35.33 -0.23%
BIIB $404.56 0.07%
BA $140.50 0.21%
CELG $118.81 -0.59%

Markets

DOW 17,683.58 -46.53 -0.26%
S&P 500 2,068.76 -8.02 -0.39%
NASDAQ 4,991.94 -17.2740 -0.34%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs